Compare · RGC vs UPXI
RGC vs UPXI
Side-by-side comparison of Regencell Bioscience Holdings Limited (RGC) and Upexi Inc. (UPXI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RGC and UPXI operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $2.74B, about 34.2x UPXI ($80.1M).
- UPXI has more recent analyst coverage (2 ratings vs 0 for RGC).
- Company
- Regencell Bioscience Holdings Limited
- Upexi Inc.
- Price
- -
- -
- Market cap
- $2.74B
- $80.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 2
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
Latest UPXI
- Upexi Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- Director Salkind Gene was granted 100,000 shares, increasing direct ownership by 46% to 318,750 units (SEC Form 4)
- Director Dugan Lawrence was granted 100,000 shares, increasing direct ownership by 86% to 216,389 units (SEC Form 4)
- Chief Strategy Officer Rudick Brian Benjamin was granted 400,000 shares, increasing direct ownership by 48% to 1,238,597 units (SEC Form 4)
- Chief Executive Officer Marshall Allan was granted 2,000,000 shares, increasing direct ownership by 49% to 6,046,261 units (SEC Form 4)
- Chief Financial Officer Norstrud Andrew James was granted 400,000 shares, increasing direct ownership by 62% to 1,049,138 units (SEC Form 4)
- SEC Form EFFECT filed by Upexi Inc.
- SEC Form 424B3 filed by Upexi Inc.
- SEC Form S-3 filed by Upexi Inc.
- Upexi Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits